Top compounds associated with response to GPR45


Feature Type Standardized
Nominal ANOVA
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.07 0.02
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.076 0.02
mRNA BX-795 GDSC1000 pan-cancer AAC -0.073 0.03
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.077 0.03
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.061 0.03
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.064 0.03
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.064 0.04
mRNA MP470 GDSC1000 pan-cancer AAC 0.069 0.04
Download CSV